Skip to content
HowShorted

Avalo Therapeutics, Inc. short interest in 2023

In 2023, Avalo Therapeutics, Inc.'s disclosed short interest ran from 0.43% of shares outstanding on 13 Jan 2023 to 6.57% on 15 Dec 2023, a change of +6.14 percentage points. The year's high was 9.43% on 15 Nov 2023 and its low 0.14% on 31 Mar 2023, averaging 2.24% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.88 days on 13 Jan 2023. Full history: Avalo Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Avalo Therapeutics, Inc. in 2023

2023 in figures

Start of year
0.43% (13 Jan 2023)
End of year
6.57% (15 Dec 2023)
Change
+6.14 pp
High
9.43% (15 Nov 2023)
Low
0.14% (31 Mar 2023)
Average
2.24%
Highest days to cover
6.88 (13 Jan 2023)
SEC filings marked
8

Every report in 2023

Avalo Therapeutics, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20230.43%6.88
31 Jan 20230.30%1.47
15 Feb 20230.20%1.00
28 Feb 20230.26%2.41
15 Mar 20230.20%1.31
31 Mar 20230.14%1.0010-K filed, results (8-K)
28 Apr 20230.28%1.14
15 May 20230.33%1.6210-Q filed, results (8-K)
31 May 20230.32%1.00
15 Jun 20230.29%1.00
15 Aug 20234.73%1.0010-Q filed, results (8-K)
31 Aug 20234.74%1.00
15 Nov 20239.43%1.0010-Q filed, results (8-K)
30 Nov 20235.31%1.00
15 Dec 20236.57%1.00

See also: Avalo Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.